ProCE Banner Activity

Retrospective Analysis for Validation of 2022 WHO and ICC Classification Systems for Patients With Myelodysplastic Syndromes

Slideset Download
Conference Coverage

LFS and OS analysis using 2022 WHO and ICC MDS classification systems applied to a large, single-institution patient database suggests potential improvements.

Released: December 16, 2022

Expiration: December 15, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

AbbVie

Amgen

AstraZeneca

Epizyme

GSK

Incyte Corporation

Jazz Pharmaceuticals

Karyopharm Therapeutics Inc.

Novartis Pharmaceuticals Corporation

Sanofi

Seagen